Targeting the calcitonin gene-related peptide (CGRP) pathway to treat these headaches may be the first focused therapeutic option to date, with the potential for promising efficacy.Read More →
Improving our understanding of the personal and societal burden of cluster headache is critical to generating greater interest in the development of new treatments and funding clinical trials.Read More →
Although rare, there are reports of painless cluster attacks or painful attacks without the autonomic symptoms characteristic of cluster headache.Read More →
Any discussion of cluster headache eventually includes treating cluster headache with psychedelics as an alternative to medical treatment.Read More →
Researchers from Italy wanted to understand why patients chose to treat cluster headache with illegal drugs instead of prescribed treatments.Read More →
Cluster headache is a trigeminal autonomic cephalalgia characterised by extremely painful, strictly unilateral, short-lasting headache attacks accompanied by ipsilateral autonomic symptoms or the sense of restlessness and agitation, or both. Read More →
